Partners

Awardees and Affiliated Institutions

  • Agilent Technologies, Inc., Cambridge, MA
  • Baylor College of Medicine, Houston, TX
  • Biomedical Hosting LLC, Arlington, MA
  • Brigham and Women’s Hospital, Cambridge, MA
  • Brown University, Providence, RI
  • Cell Signaling Technology, Danvers, MA
  • Chang Gung University, Molecular Medicine Research Center, Taoyuan City, Taiwan
  • Dana-Farber Cancer Institute, Boston, MA
  • Fluidigm Corp., Cambridge, MA
  • Fred Hutchinson Cancer Research Center, Seattle, WA
  • Georgetown University, Washington, DC
  • Harvard Medical School, Boston, MA
  • Jim Ayers Institute for Precancer Detection and Diagnosis, Nashville, TN
  • Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
  • Korea University, Seoul, South Korea
  • Massachusetts General Hospital Cancer Center, Boston, MA
  • National Center for Protein Sciences, Beijing, China
  • New York University School of Medicine, New York, NY
  • New York University School of Medicine, New York, NY
  • Northeastern University, Boston, MA
  • Ohio State University, Columbus, OH
  • Oregon Health and Science University, Portland, OR
  • Pacific Northwest National Laboratory, Richland, WA
  • SomaLogic, Boulder, CO
  • ThermoFisher Scientific, Waltham, MA
  • University of California San Diego, San Diego, CA
  • University of California San Francisco, J. David Gladstone Institutes, San Francisco, CA
  • University of California Santa Cruz Genomics Institute, Santa Cruz, CA
  • University of Chicago, Chicago, IL
  • University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
  • University of Washington School of Medicine, Seattle, WA
  • Vanderbilt University Medical Center, Nashville, TN
  • Virginia Polytechnic Institute, Bradley Department of Electrical and Computer Engineering, Arlington, VA
  • Washington University in St. Louis, MO

Additional Partners

American Association for Clinical Chemistry
NCI’s OCCPR collaborates with the American Association for Clinical Chemistry (AACC) via a MOU to join forces on promoting and educating the clinical chemistry community in the area of proteomic standards/technologies to further its application in clinical labs.

Food and Drug Administration
NCI’s OCCPR and The Food and Drug Administration (FDA) formally collaborate (through a memorandum of understanding - MOU) to accelerate the translations of proteomics technologies and applications into clinical settings in areas including sample collection; bioinformatics; experimental design; standardization of platforms.  Collaboration resulted in a summary report and mock 510(k) pre-submissions with FDA review comments published in Clinical Chemistry (see references 1, 2, 3, 4, and 5), serving as a springboard for the clinical proteomics community in the development of protein-based multiplexed In Vitro Diagnostic (IVD) tests.

National Institute of Standards and Technology
NCI’s OCCPR collaborates with the National Institute of Standards and Technology (NIST) to develop mass spectrometry-based technology assessment quality control tools and Common Data Analysis Pipeline (CDAP) used by the CPTAC teams and the broad research community.

National Heart, Lung, and Blood Institute
NCI’s OCCPR collaborates with the Proteomics Center Program of the National Heart, Lung, and Blood Institute (NHLBI) via a MOU to foster greater cooperation through the sharing of reagents and protocols, confirmation of candidate protein markers, and to facilitate the development of bioinformatics standards in proteomics.

European Bioinformatics Institute
NCI’s OCCPR works with the European Bioinformatics Institute (EBI) to coordinate bioinformatics standards development for clinical proteomics, e.g., EBI/OCCPR collaborated to develop international data standards with recommendations from the Human Proteome Organization Proteomics Standards Initiative (HUPO-PSI).

Tissue Source Sites

  • Asterand
  • Baylor College of Medicine
  • BioCell Analytics
  • Biomatrix
  • Biopartners
  • Boston Medical Center
  • Cedars-Sinai Medical Center
  • Children’s Hospital of Philadelphia
  • Cureline, Inc.
  • Duke University
  • Fidelis Research
  • H. Lee Moffitt Cancer Center and Research Institute
  • Hackensack Meridian Health – Jersey Shore University Medical Center
  • Instituto Nacional De Neurologia Y Neurocirugia
  • International Institute for Molecular Oncology
  • Johns Hopkins University
  • Memorial Sloan Kettering Cancer Center
  • New York University School of Medicine
  • ProteoGenex, Inc.
  • Roswell Park Cancer Institute
  • Spectrum Health Services
  • St. Joseph’s Hospital & Medical Center
  • Thomas Jefferson University
  • University of Calgary
  • University of California – San Diego
  • University of Iowa
  • University of Kansas Medical Center
  • University of Oklahoma
  • University of Pittsburgh
  • Vanderbilt University Medical Center
  • Washington University in St. Louis
  • William Beaumont Hospital

Biospecimen Core Resource

  • Van Andel Research Institute

Quality Management System

  • Leidos

Data Coordinating Center

  • ESAC: Enterprise Science and Computing

Commercialization

CPTAC collaborates with industry through various mechanisms, including research proposals to be funded through the Small Business Innovation Research (SBIR) program.  Find out more information on collaborative opportunities by contacting us at cancer.proteomics@mail.nih.gov